New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation

Details for Australian Patent Application No. 2001282734 (hide)

Owner Biovitrum AB

Inventors Sakariassen, Kjell S.; Nilsson, Bjorn M.; Svartengren, Jan; Jossan, Sukhwinder

Agent Davies Collison Cave

Pub. Number AU-B-2001282734

PCT Pub. Number WO02/08178

Priority 0002754 21.07.00 SE

Filing date 19 July 2001

Wipo publication date 5 February 2002

Acceptance publication date 12 October 2006

International Classifications

C07C 311/51 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/404 (2006.01)

A61K 31/497 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

12 October 2006 Application Accepted

  Published as AU-B-2001282734

8 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001282735

2001282733-Dendritic macromolecule with improved polyether polyol solubility and process for production thereof